# Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis

> **NCT06629623** · — · ENROLLING_BY_INVITATION · sponsor: **Chu Hongling** · enrollment: 310 (estimated)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT06629623
- **Lead sponsor:** Chu Hongling
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-07-30
- **Primary completion:** 2025-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 310 (ESTIMATED)
- **Last updated:** 2024-10-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06629623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06629623, "Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06629623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*